Bay Area Tumor Institute CCOP

描述（由申请人提供）： 湾区肿瘤研究所社区临床肿瘤学项目（BATI-CCOP） 是一个由七个社区和县医院组成的联盟， 奥克兰，加州，地区。自1979年作为CGOP成立以来， 在1989年转为CCOP地位后，该联合体继续提供 社区的癌症专家、初级保健医生和医院 获得国家癌症研究所批准和资助的临床试验项目整合 卫生和公众服务部出版物《2010年健康人》的目标， 阿拉米达县及其主要城市奥克兰的收入和女性人口， BATI-CCOP使癌症患者和一般“高危”人群能够 参与SWOG、NSABP、RTOG的临床和癌症控制研究， COG。在其成就的基础上， 的BATI-CCOP包括以高于 可比的CCOP，少数民族和儿科患者的入组率较高 与所有其他CCOP相比，积极的癌症控制招募和累积 超过了NCI的癌症控制研究要求， 与研究基地，并继续履行NCI的“条款， 合作“CCOP将继续100%地增加所有符合条件的儿科 该地区的肿瘤患者中， 县医院，实现少数民族和妇女参与， 超过CCOP应计总额的75%。CCOP也将继续超过 NCI授权并保持湾区在癌症预防方面的领先地位 和对照试验。BATI-CCOP提供了一个成功的长期跟踪记录， 一个有组织、有责任心的医疗团体， 调查人员，来自湾区肿瘤的机构和财政支持 研究所，和不寻常的访问非洲裔美国人，西班牙裔，亚洲，儿科， 服务不足和女性人口。

DESCRIPTION (provided by applicant): The Bay Area Tumor Institute Community Clinical Oncology Program (BATI-CCOP) is a consortium of seven community and county hospitals in the Greater Oakland, California, area. Since its creation in 1979 as a CGOP and its conversion to CCOP status in 1989, this consortium has continuously provided the community's cancer specialists, primary care physicians, and hospitals with an NCI-approved and funded clinical trials program. Integrating the goals of DHHS publication "Healthy People 2010" by targeting minority, low income and female populations in Alameda County and its main city, Oakland, the BATI-CCOP enables cancer patients and the general "at risk" population to participate in clinical and cancer control research of SWOG, NSABP, RTOG, and COG. Building on its achievements, the long-term objectives and specific aims of the BATI-CCOP include accrual to therapeutic trials at higher rates than comparable CCOP's, accrual of minority and pediatric patients at higher rates than all other CCOP's, aggressive cancer control recruitment and accrual exceeding NCI's cancer control research requirements, increased interaction with research bases, and continued fulfillment of NCI's "Terms of Cooperation." The CCOP will continue to accrue 100% of all eligible pediatric oncology patients in the region, accrue 50% of all eligible cancer patients at the county hospital, and achieve minority and female participation that will exceed 75% of the total CCOP accrual. The CCOP will also continue to exceed NCI mandates and remain the Bay Area leader in accrual to cancer prevention and control trials. The BATI-CCOP offers a successful long-term track record, an organized and committed medical community, experienced physician investigators, institutional and financial support from the Bay Area Tumor Institute, and unusual access to African American, Hispanic, Asian, pediatric, underserved, and female populations.